Document is current
Any future updates will be listed below
-
Authors
Urakawa, Tatsuki
Hattori, Atsushi
Ogiwara, Yasuko
Masubuchi, Hayate
Igarashi, Mizuho
Nakamura, Sayuri
Hara-Isono, Kaori
Ishiwata, Keisuke
Ogata-Kawata, Hiroko
Kamura, Hiromi
Kuroki, Yoko
Nakabayashi, Kazuhiko
Fukami, Maki
Kagami, Masayo
-
Funding
Funding for this research was provided by:
Japanese Society for Pediatric Endocrinology Future Development Grant supported by Novo Nordisk Pharma Ltd., the NOVARTIS Foundation
National Center for Child Health and Development (2022B-5)
Japan Society for the Promotion of Science (22K07858 [C])
Japan Agency for Medical Research and Development (JP25ek0109805)
Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics
- License Information
-
More Information
Article History
Received: 2 May 2025
Accepted: 6 October 2025
First Online: 18 November 2025
Declarations
:
: This study was approved by the Institutional Review Board Committee of the National Center for Child Health and Development (permit No. 518 and 2024–245) and complied with the Declaration of Helsinki. We obtained written informed consent from all individuals or their parents to participate in this study.
: We obtained written informed consent from the individuals and the patients or the patients’ parents to publish the individuals’ molecular information and patients’ clinical and molecular information, respectively.
: The authors declare no competing interests.
